4//SEC Filing
Vanda Pharmaceuticals Inc. 4
Accession 0001209191-17-017811
$VNDACIK 0001347178operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:33 PM ET
Size
7.6 KB
Accession
0001209191-17-017811
Insider Transaction Report
Form 4
Reverberi Gian Piero
SVP, General Manager Europe
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-01+70,000→ 70,000 totalExercise: $14.50Exp: 2027-02-28→ Common Stock (70,000 underlying) - Award
Restricted Stock Unit
2017-03-01+30,000→ 50,000 total
Footnotes (3)
- [F1]The Restricted Stock Units ("RSU") shall vest in four (4) equal annual installments beginning March 1, 2018, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]Each RSU represents a contingent right to receive a share of the Issuer's common stock.
- [F3]The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning March 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001347178
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:33 PM ET
- Size
- 7.6 KB